The Uromigos
Un podcast de The Uromigos
401 Épisodes
-
Episode 343: ESMO 2024 - TiNivo-2 Trial
Publié: 14/09/2024 -
Episode 342: ESMO 2024 Preview with Silke Gillessen
Publié: 03/09/2024 -
Episode 341: Hormone Resistance in Prostate Cancer
Publié: 27/08/2024 -
Episode 340: Cancer Immunity Cycle Update
Publié: 19/08/2024 -
Episode 339: Tres Uramigas analizan lineamientos de ESMO para GU
Publié: 09/08/2024 -
Episode 338: RCC: Debulking Nephrectomy, Adjuvant Therapy Future and More
Publié: 06/08/2024 -
Episode 337: Updated NCCN Guidelines in RCC
Publié: 30/07/2024 -
Episode 336: Which patients are not suitable for 1st line EVP in bladder cancer
Publié: 24/07/2024 -
Episode 335: Novel immune therapies for renal cancer
Publié: 19/07/2024 -
Episodio 334 en español: Tres Uramigas ASCO 2024
Publié: 11/07/2024 -
Episode 333: The Uromigos Cup - The Netherlands
Publié: 05/07/2024 -
Episode 332: The Uromigos Cup - Germany's Entry
Publié: 26/06/2024 -
Episode 331: AUA 2024 NMIBC Highlights
Publié: 21/06/2024 -
Episode 330: ASCO 2024 Highlights
Publié: 10/06/2024 -
Episode 329: Japan in the Uromigos Cup qualifying round
Publié: 07/06/2024 -
Episode 328 ASCO24: Emergency podcast - what the NADINA trial means for preoperative GU cancer studies
Publié: 05/06/2024 -
Episode 327 ASCO24: CM901 and EV302 Efficacy and QOL Updates
Publié: 04/06/2024 -
Episode 326 ASCO24: KIM-1 in Renal Cancer
Publié: 03/06/2024 -
Episode 325 ASCO24: KN426 and the CLEAR trial - tissue based biomarkers for kidney cancer
Publié: 03/06/2024 -
Episode 324 ASCO24: SURE1 neoadjuvant sacituzumab govitecan in UC
Publié: 02/06/2024
Broadcasting the latest developments in GU cancer Hosted by Brian Rini and Tom Powles Brian Rini MD is a Professor of Cancer Research and Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Center Tom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London